Market Cap 41.05M
Revenue (ttm) 2.56M
Net Income (ttm) -37.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,462.89%
Debt to Equity Ratio 3.41
Volume 1,865,500
Avg Vol 3,696,788
Day's Range N/A - N/A
Shares Out 173.66M
Stochastic %K 6%
Beta 0.39
Analysts Strong Sell
Price Target $2.67

Latest News on XFOR

X4 Pharmaceuticals, Inc. (XFOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 9:31 PM EST - 5 months ago

X4 Pharmaceuticals, Inc. (XFOR) Q3 2024 Earnings Call Transcript


X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 9:30 AM EDT - 8 months ago

X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript